AZD0156 enhances radiation-induced tumour growth inhibition, potentiates PARP inhibitors like olaparib, and shows synergistic effects with irinotecan, demonstrating promise in combinatorial cancer therapies276,.277. This evidence concerns the gene PARP1 and neoplasm.